Mefloquine Hydrochloride

CHEMBL535650 Phase 4 承認済み Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

414.8 g/mol

LogP

—

Phase

4

A hydrochloride salt form of mefloquine, an antimalarial agent used for prevention and treatment of chloroquine-resistant malaria, taken weekly for prophylaxis or as a treatment course.

分子量

414.8000 g/mol

TPSA

45.20 Å²

治療領域

Malaria

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure

Embed this structure

SMILES

Cl.OC(c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)C1CCCCN1

InChI

InChI=1S/C17H16F6N2O.ClH/c18-16(19,20)11-5-3-4-9-10(15(26)12-6-1-2-7-24-12)8-13(17(21,22)23)25-14(9)11;/h3-5,8,12,15,24,26H,1-2,6-7H2;1H

Molecular Formula

C17H17ClF6N2O

HBD / HBA

3 / 9

回転可能結合数

2

重原子数

27

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

A hydrochloride salt form of mefloquine, an antimalarial agent used for prevention and treatment of chloroquine-resistant malaria, taken weekly for prophylaxis or as a treatment course.

Yes, Mefloquine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL535650. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 65329. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

患者向けのわかりやすい情報をお探しですか？

Mefloquine Hydrochloride PillFYIで

構造

クイックデータ

分子式: C17H17ClF6N2O

外部リンク

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.